Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

NCT00332553 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasomotor Symptoms
Endometrial Safety

Interventions

DRUG: Raloxifene
DRUG: medroxyprogesterone acetate
DRUG: estrogen
DRUG: 17 beta estradiol

Sponsor

Eli Lilly and Company